Global Newborn Screening Instruments Market Research Report 2019
Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isnt otherwise apparent at birth.
The classification of newborn screening instruments includes disorder screening, hearing screening and pulse oximetry screening, and the revenue proportion of disorder screening in 2017 is about 64%.
Newborn Screening Instruments is widely used for Hearing Screening Test, CCHD Test, Dry Blood Spot Test and other. The most proportion of Newborn Screening Instruments is used in Dry Blood Spot Test and the proportion in 2017 is about 46%.
North America is the largest supplier of Newborn Screening Instruments, with a revenue market share nearly 63% in 2017. Europe is the second largest supplier of Newborn Screening Instruments Media, enjoying revenue market share nearly 26% in 2017.
North America is the largest consumption place, with a consumption market share nearly 46% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 33%.
The global Newborn Screening Instruments market is valued at 470 million US$ in 2018 is expected to reach 910 million US$ by the end of 2025, growing at a CAGR of 8.6% during 2019-2025.
This report focuses on Newborn Screening Instruments volume and value at global level, regional level and company level. From a global perspective, this report represents overall Newborn Screening Instruments market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Segment by Regions
Segment by Type
Pulse Oximetry Screening
Segment by Application
Hearing Screening Test
Dry Blood Spot Test